Marshall Wace’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.2M Buy
+891,520
New +$9.04M 0.01% 920
2025
Q4
Sell
-358,052
Closed -$3.36M 2913
2025
Q3
$3.36M Sell
358,052
-458,481
-56% -$4.27M ﹤0.01% 1366
2025
Q2
$7.32M Buy
816,533
+382,609
+88% +$3.05M 0.01% 966
2025
Q1
$3.78M Buy
433,924
+49,881
+13% +$502K ﹤0.01% 1193
2024
Q4
$3.2M Buy
384,043
+170,181
+80% +$1.26M ﹤0.01% 1258
2024
Q3
$1.27M Sell
213,862
-230,336
-52% -$1.28M ﹤0.01% 1552
2024
Q2
$2.34M Buy
444,198
+432,372
+3,656% +$2.2M ﹤0.01% 1290
2024
Q1
$64.3K Sell
11,826
-39,294
-77% -$251K ﹤0.01% 2333
2023
Q4
$375K Sell
51,120
-5,372
-10% -$35.4K ﹤0.01% 1815
2023
Q3
$465K Buy
+56,492
New +$502K ﹤0.01% 1747
2023
Q1
Sell
-18,320
Closed -$330K 2599
2022
Q4
$330K Sell
18,320
-8,453
-32% -$170K ﹤0.01% 2529
2022
Q3
$533K Buy
26,773
+14,546
+119% +$317K ﹤0.01% 2691
2022
Q2
$213K Buy
+12,227
New +$221K ﹤0.01% 3152
2021
Q4
Sell
-15,199
Closed -$285K 3814
2021
Q3
$285K Buy
+15,199
New +$320K ﹤0.01% 2671
2014
Q3
Sell
-16,600
Closed -$374K 856
2014
Q2
$374K Buy
+16,600
New +$376K 0.01% 671

Other funds holding ADTN

Marshall Wace's ADTN Position: Q1 2026 in Review

Marshall Wace opened a new position in Adtran (ADTN) in Q1 2026: 891,520 shares worth $11.2M. The stake represents 0.01% of the portfolio and ranks #920 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ADTN as recently as Q3 2025.

Marshall Wace first reported a position in ADTN in Q2 2014 and has held it in 15 quarters since. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

  • Marshall Wace held 891,520 shares of Adtran worth $11.2M as of Q1 2026.
  • Adtran was a new Marshall Wace position in Q1 2026.
  • Adtran made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #920 holding.
  • Marshall Wace first reported a position in Adtran in Q2 2014 and has held it in 15 quarters since.
  • 227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.